Harris Associates
ELV icon

Harris Associates’s Elevance Health ELV Stock Holding History

Harris Associates’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.9B Buy
4,924,511
+127,985
+3% +$47.5M 2.53% 11
2026
Q1 		$1.4B Buy
4,796,526
+2,081
+0% +$684K 1.87% 16
2025
Q4 		$1.68B Buy
4,794,445
+1,604,821
+50% +$542M 2.12% 16
2025
Q3 		$1.03B Buy
3,189,624
+902,059
+39% +$281M 1.65% 21
2025
Q2 		$890M Buy
2,287,565
+7,406
+0.3% +$2.98M 1.45% 28
2025
Q1 		$992M Buy
2,280,159
+458,875
+25% +$184M 1.67% 24
2024
Q4 		$672M Buy
+1,821,284
New +$762M 0.88% 37

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Harris Associates's ELV Position: Q2 2026 in Review

Harris Associates increased its Elevance Health (ELV) stake by 2.7% in Q2 2026, buying an estimated $47.5M and bringing the position to 4,924,511 shares worth $1.9B. The position accounts for 2.53% of the portfolio, ranked #11.

Harris Associates first reported a position in ELV in Q4 2024 and has held it in 7 quarters since. 1,596 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Harris Associates held 4,924,511 shares of Elevance Health worth $1.9B as of Q2 2026.
  • Harris Associates bought 127,985 Elevance Health shares in Q2 2026, an estimated $47.5M.
  • Elevance Health made up 2.53% of Harris Associates's portfolio in Q2 2026, its #11 holding.
  • Harris Associates first reported a position in Elevance Health in Q4 2024 and has held it in 7 quarters since.
  • 1,596 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Harris Associates's 13F filing for Q2 2026, filed 14 Aug 2026.